from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1845c/blaR

LFCtreatmentdescriptionclass of inhibitor

-0.459

Amikacinug/mL Amikacintranslation

-0.714

Cap5-10ug/mL Capreomycintranslation

-0.121

Rox10-50 ug/mL Roxithromycintranslation

0.039

SM2-5 ug/mL Streptomycintranslation

0.304

Tet5-10 ug/mL Tetracyclinetranslation

-1.075

Rif0.2-5ug/mL Rifampicintranscription

-0.307

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.511

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.707

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.950

CPZ10-50 ug/mL Chlorpromazinerespiration

1.000

Clofazimine10-13 ug/mL Clofaziminerespiration

0.280

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.286

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

1.560

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.095

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.275

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.057

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.743

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.950

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.685

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

2.602

KCN5-20 ug/mL Potassium cyaniderespiration

0.842

NaN30.2-2 mM Sodium aziderespiration

-0.446

Nigericin50 uM Nigericinrespiration

0.895

TRC10-150 ug/mL Triclosanrespiration

0.813

TRZ10-25 ug/mL Thioridazinerespiration

-0.741

Valinomycin0.5-10 uM Valinomycinrespiration

0.487

ZnSO42 mM ZnSO4respiration

-0.196

menadione6-10 ug/mL Menadionerespiration

0.196

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.287

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.137

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.311

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.376

NRP_1Non-replicating persistence stage 1dosRassociated

-0.068

Amp0.2mg/mL AmpicillincellWall

-0.212

Cephalexin20-100 ug/mL CephalexincellWall

-0.824

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.736

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.598

EMB10-20 ug/mL EthambutolcellWall

-0.191

Eta12-40 ug/mL EthionamidecellWall

0.295

INH0.2-0.4 ug/mL IsoniazidcellWall

0.170

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.090

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.030

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.265

BZA0.12 mg/mL BenzamidearomaticAmides

-0.420

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.413

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.016

H2O24 mM hydrogen peroxideDNAdamaging

-0.096

Levo10 ug/mL LevofloxacinDNAdamaging

-0.615

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.323

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.198

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.787

UVUV-irradiationDNAdamaging

0.866

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.678

Antimycin12.5-50 ug/mL Antimycin A?

-0.708

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.179

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.459

PA_2110-50 ug/mL Antitubercular compound PA-21?

3.173

PA8240.2-2 ug/mL PA-824?

1.506

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.592

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.926

Verapamil50 uM Verapamil?

-0.632

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.626

methoxatin10-20 ug/mL Methoxatin?